Cytosorbents is a critical care immunotherapy company focused on research, development and commercialization of medical devices with its platform blood purification technology which uses a proprietary adsorbent polymer technology. Principal product, CytoSorb device, is an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis and for the adjunctive therapy in other critical care applications. For more information, visit the company’s website at www.cytosorbents.com